A high MKI is an indicator of poor prognosis in cancers such as neuroblastoma (NB)29–31; and finally, (iii) Bax and Bcl2 markers, used to characterize cellular signals of apoptosis and antiapoptosis activity, respectively32–35. Here, BCL2 is linked to neuroblastoma.